Background: Concentrations of the anti-angiogenic factor soluble fms-like tyrosine kinase-1
(sFlt-1) are altered in peripartum cardiomyopathy (PPCM). In this study we investigated …

Objectives: This study explored the association of vascular hormones with myocardial
recovery and clinical outcomes in peripartum cardiomyopathy (PPCM). Background: PPCM …

Background—Recent studies suggest that angiogenic imbalance during pregnancy may
lead to acute peripartum cardiomyopathy (PPCM). We propose that angiogenic imbalance …

Background Angiogenic imbalance involving the placental protein soluble Fms-like tyrosine
kinase-1 (sFlt-1) and cleavage of the nursing-hormone prolactin by the enzyme cathepsin D …

Background The angiogenic factors soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and
placental growth factor (PlGF) are postulated to be pathogenic disease drivers of …

BACKGROUND: Placental growth factor (PlGF), which is a member of the vascular
endothelial growth factor family, stimulates angiogenesis and collateral growth in ischemic …

Background There is little knowledge about the significance of extremely high values (> 655)
for the ratio of sF lt‐1 (soluble fms‐like tyrosine kinase 1) to Pl GF (placental growth factor) …

Objective To investigate the relationship between fetal heart defects and maternal serum
placental growth factor (PlGF), a marker of placental angiogenesis. Methods Maternal serum …

Objective To investigate the predictive values of placental growth factor (PlGF) and its
endogenous antagonist, soluble fms-like tyrosine kinase-1 (sFlt-1), for the long-term …

Background: Preeclampsia and fetal growth restriction (FGR) are both associated with an
increased ratio of sFLT1 (soluble fms-like tyrosine kinase-1) to PlGF (placenta growth factor) …